相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Knockdown of growth differentiation factor-15 inhibited nonsmall cell lung cancer through inactivating PTEN/PI3K/AKT signaling pathway
Yongshi Liu et al.
GENES & GENOMICS (2023)
Cell Cycle-Dependent Transcription: The Cyclin Dependent Kinase Cdk1 Is a Direct Regulator of Basal Transcription Machineries
Jorrit M. Enserink et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Macrophage inhibitory cytokine-1 produced by melanoma cells contributes to melanoma tumor growth and metastasis in vivo by enhancing tumor vascularization
Jaeseob Lee et al.
MELANOMA RESEARCH (2022)
Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers
Hui-Yan Sun et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2022)
EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma
Guangtong Deng et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
BECN2 (beclin 2) Negatively Regulates Inflammasome Sensors Through ATG9A-Dependent but ATG16L1-and LC3-Independent Non-Canonical Autophagy
Guangtong Deng et al.
AUTOPHAGY (2022)
Morusin enhances the antitumor activity of MAPK pathway inhibitors in BRAF-mutant melanoma by inhibiting the feedback activation of STAT3
Kun Zhao et al.
EUROPEAN JOURNAL OF CANCER (2022)
A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma
Abdullah Al Emran et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Metformin alleviates bevacizumab-induced vascular endothelial injury by up-regulating GDF15 and activating the PI3K/AKT/FOXO/ PPAR gamma signaling pathway
Liqiang Chen et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15
Feng Guo et al.
CELL DEATH DISCOVERY (2021)
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Dongdong Wang et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Recent Advances in the Treatment of Melanoma
Brendan D. Curti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Induction of cell cycle arrest and apoptosis by CPUC002 through stabilization of p53 and suppression of STAT3 signaling pathway in multiple myeloma
Yue Zhao et al.
CELL BIOLOGY AND TOXICOLOGY (2021)
Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma
Manoela Tiago et al.
BRITISH JOURNAL OF CANCER (2020)
Comprehensive Proteomics Analysis of Stressed Human Islets Identifies GDF15 as a Target for Type 1 Diabetes Intervention
Ernesto S. Nakayasu et al.
CELL METABOLISM (2020)
Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction
Mingzhu Yin et al.
NATURE COMMUNICATIONS (2020)
BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbine
Deepak Kanojia et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway
Guangtong Deng et al.
THERANOSTICS (2020)
Inhibition of NF-κB-Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma
Grazia Ambrosini et al.
CANCER RESEARCH (2019)
Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies
Stephen A. Luebker et al.
FRONTIERS IN ONCOLOGY (2019)
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai et al.
CANCER CELL (2019)
Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma
Vivian Chua et al.
EMBO MOLECULAR MEDICINE (2019)
Propranolol enhanced the anti-tumor effect of sunitinib by inhibiting proliferation and inducing G0/G1/S phase arrest in malignant melanoma
Xinwei Kuang et al.
ONCOTARGET (2018)
Down-regulation of STAT3 induces the apoptosis and G1 cell cycle arrest in esophageal carcinoma ECA109 cells
Chao Zhou et al.
CANCER CELL INTERNATIONAL (2018)
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells
Fiona Simpkins et al.
CLINICAL CANCER RESEARCH (2018)
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma
Ileabett M. Echevarria-Vargas et al.
EMBO MOLECULAR MEDICINE (2018)
The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma
Bei Zhao et al.
MELANOMA RESEARCH (2018)
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated state
Mohammad Fallahi-Sichani et al.
MOLECULAR SYSTEMS BIOLOGY (2017)
Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition
Lu Yang et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation
Chunying Song et al.
CANCER DISCOVERY (2017)
High GDF-15 Serum Levels Independently Correlate with Poorer Overall Survival of Patients with Tumor-Free Stage III and Unresectable Stage IV Melanoma
Benjamin Weide et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
Zhenfeng Zhang et al.
THERANOSTICS (2016)
BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma
Luca Paoluzzi et al.
CANCER MEDICINE (2016)
HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPL
Robbie Carson et al.
CLINICAL CANCER RESEARCH (2015)
Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells
Anil Korkut et al.
ELIFE (2015)
BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy
Miguel F. Segura et al.
CANCER RESEARCH (2013)
The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
Xiaofeng Jiang et al.
CLINICAL CANCER RESEARCH (2013)
Sunitinib Therapy for Melanoma Patients with KIT Mutations
David R. Minor et al.
CLINICAL CANCER RESEARCH (2012)
Plasma Markers for Identifying Patients with Metastatic Melanoma
Harriet M. Kluger et al.
CLINICAL CANCER RESEARCH (2011)
Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
Hong Xin et al.
CANCER RESEARCH (2009)
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko et al.
CLINICAL CANCER RESEARCH (2009)
Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
James H. Finke et al.
CLINICAL CANCER RESEARCH (2008)
CDC6:: from DNA replication to cell cycle checkpoints and oncogenesis
Luis R. Borlado et al.
CARCINOGENESIS (2008)
The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury
T Kempf et al.
CIRCULATION RESEARCH (2006)
分享论文
